lepromatous


Also found in: Dictionary, Thesaurus, Encyclopedia.

lep·rom·a·tous

(lep-rō'mă-tŭs),
Pertaining to, or characterized by, the features of a leproma.

lep·rom·a·tous

(lep-rō'mă-tŭs)
Pertaining to, or characterized by, the features of a leproma.
References in periodicals archive ?
* It is an advanced stage of macular type of lepromatous leprosy with easily visible infiltration.
A possible explanation of this phenomenon is reduced release of vasoactive amines and reduced substance Pmediated immunostimulation and cellular proliferation, which results from reduced neuropeptide release because of nerve damage in lepromatous skin lesions (11).
Pancytopenia due to lepromatous involvement of the bone marrow: Successful treatment with multidrug therapy.
Waters, "Evidence for circulating immune complexes in lepromatous leprosy," The Lancet, vol.
The appearance of "pudgy" deformed fingers is certainly misleading, but it may constitute an unsuspected inaugural form of leprosy, especially in its lepromatous form [9].
(d) Indeterminate leprosy, GRP78/BiP antibody; (e) tuberculoid leprosy, GRP78/BiP antibody; (f) lepromatous leprosy, GRP78/BiP antibody; (j) indeterminate leprosy, PERK antibody; (k) tuberculoid leprosy, PERK antibody; (l) lepromatous leprosy, PERK antibody; (g) indeterminate leprosy, IRE1[alpha] antibody; (h) tuberculoid leprosy, IRE1[alpha] antibody; (i) lepromatous leprosy, IRE1[alpha] antibody; (a) indeterminate leprosy, ATF6 antibody; (b) tuberculoid leprosy, ATF6 antibody; (c) lepromatous leprosy, ATF6 antibody.
(2004) had similar case numbers with confirmed neuropathic pain, using the same exclusion criteria, clinical presentation (lepromatous leprosy), pain assessment procedures and also the McGill Pain Questionnaire.
On the other hand lepromatous leprosy seen in patients with poor cell mediated immunity tends to cause multiple, asymmetrical skin lesions with irregular margins [3].
Type 2 reaction is observed in borderline lepromatous and lepromatous leprosy and, usually, presents as crops of erythematous tender nodules and plaques over extremities, trunk, face, and other body parts.
The 1978 data were presented separately for contacts of "lepromatous" (three arms: placebo, low dose, and usual dose) and of "non-lepromatous" index cases (two arms: placebo and dapsone).
The NOD2 pathway was inhibited and could not be activated in lepromatous leprosy, which is more serious and causes widespread infection throughout the body.
In a study conducted on 2,517 patients in Dhaka, Bangladesh, it was observed that 2.1% patients suffered from Indeterminate form of leprosy, 52.7% suffered from tuberculoid form, 17.4% suffered from borderline tuberculoid form, 4.4% suffered from borderline lepromatous form, and 23.4% suffered from the lepromatous form of the disease (Choudhury, A.M., 1991).